您的当前位置:首页 > 行业数据 > 全球(中国除外)PD-1靶向双抗/双功能融合蛋白竞争格局(截至2025年12月
图片属性
图片格式:PNG 图片大小:123KB 图片尺寸:1889*845
同报告图片
 / 4
全球(中国除外)PD-1靶向双抗/双功能融合蛋白竞争格局(截至2025年12月_第1页
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
全球(中国除外)PD-1靶向双抗/双功能融合蛋白竞争格局(截至2025年12月_第2页
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+6Z2254K5PC90aD4KICAgICAgICAgICAgPHRoPuS6p+WTgTwvdGg+CiAgICAgICAgICAgIDx0aD7lhazlj7g8L3RoPgogICAgICAgICAgICA8dGg+6YCC5bqU55eHPC90aD4KICAgICAgICAgICAgPHRoPuS4tOW6iumYtuautTwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+Q1RMQTTjgIFDRDQ3PC90ZD4KICAgICAgICAgICAgPHRkPkhYMDQ0PC90ZD4KICAgICAgICAgICAgPHRkPue/sOaAneeUn+eJqTwvdGQ+CiAgICAgICAgICAgIDx0ZD7mmZrmnJ/lrp7kvZPnmKTmgbbmgKfogr/nmKQ8L3RkPgogICAgICAgICAgICA8dGQ+SS9JSWHmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQgcm93c3Bhbj0iMyI+Q1RMQTTjgIFQRCAtIDE8L3RkPgogICAgICAgICAgICA8dGQgcm93c3Bhbj0iMyI+Vm9scnVzdG9taW5nL01FRDE1NzUyPC90ZD4KICAgICAgICAgICAgPHRkIHJvd3NwYW49IjMiPumYv+aWr+WIqeW6tzwvdGQ+CiAgICAgICAgICAgIDx0ZD5OU0NMQ+OAgeWxgOmDqOaZmuacn+Wuq+miiOeZjOOAgeS4jeWPr+WIh+mZpOeahOiDuOiGnOmXtOearueYpOOAgUhOU0ND44CB5pma5pyf6IK+6YCP5piO57uG6IOe55mMPC90ZD4KICAgICAgICAgICAgPHRkPklJSeacnzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5IQ0PjgIFCVEPjgIHmmZrmnJ/lrp7kvZPnmKTjgIHovaznp7vmgKfnu5Pnm7TogqDnmYzjgIHlsYDpg6jmmZrmnJ/kuI3lj6/liIfpmaTmiJbovaznp7vmgKfog4PnmYzmiJbog4Ppo5/nrqHkuqTnlYzohbrnmYw8L3RkPgogICAgICAgICAgICA8dGQ+SUnmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+UkND44CB6L2v57uE57uH6IKJ55ikPC90ZD4KICAgICAgICAgICAgPHRkPknmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICA8L3Rib2R5Pgo8L3RhYmxlPgoK5pWw5o2u5p2l5rqQ77ya5oub6IKh6K+05piO5Lmm44CB6I2v5a6h5Lit5b+D44CB5paH54yu57u86L+w44CB5byX6Iul5pav54m55rKZ5Yip5paH44CB5Zu95oqV6K+B5Yi45Zu96ZmFCmBgYA==
全球(中国除外)PD-1靶向双抗/双功能融合蛋白竞争格局(截至2025年12月_第3页
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+6Z2254K5PC90aD4KICAgICAgICAgICAgPHRoPuS6p+WTgTwvdGg+CiAgICAgICAgICAgIDx0aD7lhazlj7g8L3RoPgogICAgICAgICAgICA8dGg+6YCC5bqU55eHPC90aD4KICAgICAgICAgICAgPHRoPuS4tOW6iumYtuautTwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+UEQgLSAx44CBQ0Q0NzwvdGQ+CiAgICAgICAgICAgIDx0ZD5IWDAwOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7nv7DmgJ3nlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+5pma5pyf5a6e5L2T55ikPC90ZD4KICAgICAgICAgICAgPHRkPkkg5pyfPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPlBEIC0gMeOAgVBEIC0gTDE8L3RkPgogICAgICAgICAgICA8dGQ+Q1RYIC0gODM3MTwvdGQ+CiAgICAgICAgICAgIDx0ZD5Db21wYXNzIFRoZXJhcGV1dGljczwvdGQ+CiAgICAgICAgICAgIDx0ZD5OU0NMQ+OAgVROQkPjgIFITlNDQyDnrYk8L3RkPgogICAgICAgICAgICA8dGQ+SSDmnJ88L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+UEQgLSAx44CBSUwyMTwvdGQ+CiAgICAgICAgICAgIDx0ZD5BTUcyNTY8L3RkPgogICAgICAgICAgICA8dGQ+5a6J6L+bICsg5L+h6L6+55Sf54mpPC90ZD4KICAgICAgICAgICAgPHRkPuaZmuacn+WunuS9k+eYpDwvdGQ+CiAgICAgICAgICAgIDx0ZD5JIOacnzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5QRCAtIDHjgIFIRVIyPC90ZD4KICAgICAgICAgICAgPHRkPlNTR0o3MDU8L3RkPgogICAgICAgICAgICA8dGQ+5LiJ55Sf5Yi26I2vICsg5LiJ55Sf5Zu95YGlPC90ZD4KICAgICAgICAgICAgPHRkPuaZmuacn+aIlui9rOenu+aApyBIRVIyIOihqOi+vuWunuS9k+eYpDwvdGQ+CiAgICAgICAgICAgIDx0ZD5JIOacnzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5QRCAtIDHjgIFMSUxSQjI8L3RkPgogICAgICAgICAgICA8dGQ+QlNJIC0gNTg1PC90ZD4KICAgICAgICAgICAgPHRkPkNlbGxkZXggVGhlcmFwZXV0aWNzPC90ZD4KICAgICAgICAgICAgPHRkPuWunuS9k+eYpDwvdGQ+CiAgICAgICAgICAgIDx0ZD5JIOacnzwvdGQ+CiAgICAgICAgPC90cj4KICAgIDwvdGJvZHk+CjwvdGFibGU+CgrmlbDmja7mnaXmupDvvJrmi5vogqHor7TmmI7kuabjgIHoja/lrqHkuK3lv4PjgIHmlofnjK7nu7zov7DjgIHlvJfoi6Xmlq/nibnmspnliKnmlofjgIHlm73mipXor4HliLjlm73pmYUKYGBg
全球(中国除外)PD-1靶向双抗/双功能融合蛋白竞争格局(截至2025年12月_第4页
全球(中国除外)PD-1靶向双抗/双功能融合蛋白竞争格局(截至2025年12月_第5页
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
所属报告: 翰思艾泰~B(3378.HK):港股公司研究报告:深度IPO点评-251216(14页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠